Home Topics OMICs miRNA BIOMARKERS FOR DRUG-INDUCED LIVER INJURY miRNA BIOMARKERS FOR DRUG-INDUCED LIVER INJURY March 12, 2009 – Interview with David Galas, Ph.D., Senior Vice President of Strategic Partnerships, Institute for Systems Biology /wp-content/uploads/2018/09/gc254_3_12_2009.mp3 PodcastsResourcesBiomarkersCellular, Molecular and Developmental BiologyComputational biologyDiagnosisDrug-induced liver injuryHepatic injuryMedicine, Diagnosis, and TherapeuticsmiRNA (RNA isoforms)Molecular biologyMolecular biomarkerOrgan injuryRNA biologyRNA biomarkerRNA isoformsSystemic conditionsSystems biologyTechnology and Computational BiologyTrauma and injury Also of Interest Mitotic Stopwatch Monitors and Prevents Division of Defective Cells HIV-Free Hopes Raised by Reservoir-Targeting VLPs Rising from the Ashes: FDA Grants EUA to Invivyd COVID-19 Antibody Novo Nordisk to Acquire Cardior for Up to $1.1B, Boosting Cardiovascular Pipeline StockWatch: CDMOs Tumble as Congress Takes Aim at Chinese Biotechs Single Motor Neurons Analyzed in 3D in a Moving Fly Body Related Media Carl Icahn States His Case for Change at Illumina on "Close to the Edge" Celebrating DNA: Matthew Cobb's Reflections on the Double Helix Emerging Markets Collaborate to Succeed in Post-Pandemic World The Sun Sets on AGBT: A Report from the Last Day Spatial, Sequencing, and Sun: A Report from Day 2 of AGBT Sand, Sea, and Sequencing: Julianna LeMieux Surfs up AGBT's Hot News Related Content Mitotic Stopwatch Monitors and Prevents Division of Defective Cells HIV-Free Hopes Raised by Reservoir-Targeting VLPs Rising from the Ashes: FDA Grants EUA to Invivyd COVID-19 Antibody Novo Nordisk to Acquire Cardior for Up to $1.1B, Boosting Cardiovascular Pipeline